Form 4 Tracker
Ryan Cohlhepp

Director, President and COO · 7 filings · Latest: Apr 15, 2026

Bicara Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BCAX
Cohlhepp RyanOct 6, 2025
Proposed Sale
$18.0639,600$715.0K

← Previous

Page 2 of 2